| Number of shares | Weighted average grant date fair value | ||||||||||||||||||||||||||||||||||||
| Outstanding as of July 31, 2024 | 963,130 | $135.82 | RSU awards granted | 114,688 | 192.78 | PSU awards granted | 157,803 | 190.09 | PSU-EX granted | 51,366 | 167.95 | Share adjustments based on performance | (31,861) | 102.80 | Vested | (403,327) | 134.61 | Forfeited | (20,378) | 143.18 | Outstanding as of October 31, 2024 | 831,421 | $157.64 | ||||||||||||||
| Three months ended | October 31, | 2024 | 2023 | Ordinary shares: | Balance at beginning of period | 232,171,182 | 232,171,182 | Treasury shares canceled | (30,827,929) | — | Ordinary shares canceled | (201,343,253) | — | Balance at end of period | — | 232,171,182 | Common stock: | Balance at beginning of period | — | — | Common stock issued | 201,343,253 | — | Balance at end of period | 201,343,253 | — | Treasury shares: | Balance at beginning of period | (30,827,929) | (27,893,680) | Treasury shares canceled | 30,827,929 | — | Share repurchases | (1,310,163) | (697,398) | Treasury shares used to settle share-based compensation awards | 248,690 | 208,115 | Balance at end of period | (1,061,473) | (28,382,963) | Employee Benefit Trusts: | Balance at beginning of period | — | (274,031) | Employee Benefit Trust shares used to settle share-based compensation awards | — | 253,212 | Balance at end of period | — | (20,819) | Total shares outstanding at end of period | 200,281,780 | 203,767,400 | |||||||||||||||||||||||||||||||||||||||||||||
| Three months ended | October 31, | (In millions, except per share amounts) | 2024 | 2023 | Net sales | $7,772 | $7,708 | Operating profit | 665 | 739 | Net income | 470 | 519 | Earnings per share - diluted | 2.34 | 2.54 | Net cash provided by operating activities | 345 | 557 | Supplemental non-GAAP financial measures:(1) | Adjusted operating profit | 706 | 773 | Adjusted earnings per share - diluted | 2.45 | 2.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Three months ended | October 31, | (In millions) | 2024 | 2023 | Net sales | $403 | $379 | Adjusted operating profit | 23 | 23 | ||||||||||||||||||||||||||||||||||
| As of | ||||||||||||||
| (In millions) | October 31, 2024 | July 31, 2024 | ||||||||||||
| Short-term debt | $550 | $150 | Long-term debt | 3,447 | 3,774 | Total debt | $3,997 | $3,924 | ||||||
